BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal

Jul.07.2025
BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal
Charlie’s Holdings has amended its deal with BAT’s R.J. Reynolds Vapor, selling three more PACHA synthetic nicotine e-cigarette products for $1.5 million. This brings BAT’s total acquisition to 15 CHUC products submitted for PMTA since April.

Key Points:

 

·The parties involved in the transaction are as follows: the seller is Charlie's Holdings, Inc. (CHUC); the buyer is R.J. Reynolds Vapor Company (a subsidiary of British American Tobacco).

 

·Transaction update: CHUC and R.J. Reynolds have revised their original asset purchase agreement; additional sale of 3 PACHA brand synthetic nicotine e-cigarette products and related assets.

 

·Transaction amount and payment method: the transaction amount for this transaction is $1.5 million; Disposable payment has been completed at the time of transaction delivery.

 

·Product compliance status: All three products have been submitted for PMTA (Pre-Market Tobacco Product Application) in 2022. They belong to the category of disposable e-cigarette products containing synthetic nicotine.

 

·Cumulative transaction overview: Prior to this, CHUC had already completed its first transaction on April 16, 2024, selling 12 similar products. Currently, R.J. Reynolds has acquired a total of 15 CHUC products.

 


【2Firsts news flash】According to a report from Charlie's Holdings, Inc. (OTC: CHUC), CHUC has reached a revised agreement with R.J. Reynolds Vapor Company, a subsidiary of British American Tobacco (BAT), for the purchase of existing assets. Under the new agreement, CHUC will sell three PACHA brand synthetic nicotine products and related assets to the buyer for $1.5 million, with payment made at the time of the transaction.

 

The report indicates that these three products were previously submitted for PMTA (Pre-Market Tobacco Product Application) by CHUC in 2022.

 

Previously, CHUC announced that it had reached and completed an asset sale transaction with R.J. Reynolds Vapor Company on April 16. According to the agreement, Charlie's sold to R.J. Reynolds its 12 PACHA disposable e-cigarette products that have submitted PMTA (premarket tobacco product application) along with their related assets, all of which use synthetic nicotine. According to a comparative analysis by 2Firsts, these products are part of the PACHA Syn 3000 series.

 

2Firsts has collected the parameter information of the PACHA syn 3000 series products, as shown in the table below:

 

解读|雷诺收购PMTA在审一次性电子烟:“水果+冰”口味及高浓度尼古丁为主 口数均为3000口
Pacha Syn 3000 Product Information | Design: 2Firsts

 

In terms of specifications, the Pacha Syn 3000 products all use synthetic nicotine with concentrations of 20mg and 50mg. In terms of appearance, the Pacha Syn 3000 features a cylindrical design and is equipped with a large capacity 1200mAh battery.

 

With the completion of this transaction, R.J. Reynolds Vapor Company has now acquired a total of 15 products under the CHUC brand.

 

雷诺烟草500万美元收购12款PMTA在审一次性电子烟 均为合成尼古丁产品
PACHA Brand Product Images | Image Source: PACHA Official Website

 

CHUC stated in its 8-K report filed with the U.S. Securities and Exchange Commission that the detailed text of this agreement has been included as Exhibit 10.1 in the filing and officially incorporated into the report.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.
May.08 by 2FIRSTS.ai
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada’s federal health minister, Majorie Michel, said she is looking into legislation that would permanently ban the sale of tobacco products to anyone born after 2008. She said Canada has seen the approach recently proposed in the United Kingdom and is reviewing it with partners. Health Canada previously said the Government of Canada has invested C$66 million annually since 2018 to help Canadians quit smoking and reduce the harms of nicotine addiction.
Apr.29 by 2FIRSTS.ai
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13